89bio Inc (NASDAQ: ETNB) released topline data from the blinded extension phase of its Phase 2b ENLIVEN trial evaluating treatment with pegozafermin in patients with
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Monday.
The Dow traded down 0.23% to 35,310.40 while the NASDAQ rose 0.21% to 14,280.12. The S&P 500 also fell, dropping, 0.07% to 4,556.10.
Xenon Pharmaceuticals Inc (NASDAQ: XENE) reported topline results from the Phase 2 proof-of-concept X-NOVA trial, which evaluated the clinical efficacy, safety, and tolerability of 10 mg and 20 mg of XEN1101 in 168 patients with moderate to severe
nLIGHT Inc (NASDAQ: LASR) shares are trading higher by 8.7% to $12.38 Monday morning after the company announced a $34.5 million contract for DE M-SHORAD
Shares of electric vertical take-off and landing jet company Lilium N.V. (NASDAQ: LILM) are trading higher Monday after the company announced it received European Union Aviation Safety Agency (EASA)
Arvinas Inc (NASDAQ: ARVN) shares are trading higher by 11.2% to $24.32 Monday morning after the company announced an oversubscribed $350 million private placement.